Knowing when a claim could benefit from a referral to field case management can be complicated. In this video, we have outlined key medical considerations that can guide your decision-making. If any of these factors apply to your claim, it may be time to make a referral. Our expert staff of case managers is here to help facilitate timely and appropriate medical care while coordinating a safe and timely return to work.
Latest milestone achieved in less than a year due to rapid adoption and utilization of the patented collision repair diagnostic system
Designation makes Mitchell the exclusive supplier of diagnostic and calibration tools for certified PDR technicians.
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.